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Amyloid β-protein (Aβ) plays a central role in the pathogenesis of Alzheimer’s disease,
the most common age-associated neurodegenerative disorder. Aβ is generated through
intramembrane proteolysis of the β-carboxyl terminal fragment (βCTF) of β-amyloid
precursor protein (APP) by γ-secretase. The initial cleavage by γ-secretase occurs in the
membrane/cytoplasm boundary of the βCTF, liberating the APP intracellular domain (AICD).
The remaining βCTFs, which are truncated at the C-terminus (longer Aβs), are then cropped
sequentially in a stepwise manner, predominantly at three residue intervals, to generate
Aβ. There are twomajor Aβ product lines which generate Aβ40 and Aβ42 with concomitant
release of three and two tripeptides, respectively. Additionally, many alternative cleavages
occur, releasing peptides with three to six residues. These modulate the Aβ product
lines and define the species and quantity of Aβ generated. Here, we review our current
understanding of the intramembrane cleavage of the βCTF by γ-secretase, which may
contribute to the future goal of developing an efficient therapeutic strategy for Alzheimer’s
disease.
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INTRODUCTION
Amyloid β-protein (Aβ) is a key molecule in the pathogenesis of
Alzheimer’s disease (AD), which is the most common dementia
among elderly people and is characterized by memory loss and
cognitive decline. The Aβ is a 37–43 amino acid hydrophobic pro-
tein that constitutes senile plaques, a neuropathological hallmark
of AD (Reviewed in Selkoe, 2011). Among the various Aβ species
with variable C-terminal lengths, Aβ42 is believed to be the most
neurotoxic and aggregation-prone species (Iwatsubo et al., 1994;
Kuperstein et al., 2010), and its production and deposition can
be enhanced by familial AD (FAD)-associated mutations. Thus,
the regulation of the Aβ produced is a current central issue in
the therapeutics for AD; although it has not yet been successful
(Extance, 2010).
Aβ is produced from β-amyloid precursor protein (APP)
through successive cleavages mediated by two aspartyl mem-
brane proteases, β- and γ-secretases. The ectodomain shedding
of APP by β-secretase generates a 99 amino-acid β-carboxyl ter-
minal fragment (βCTF), an immediate substrate for γ-secretase.
The generated βCTF is then processed by γ-secretase within the
transmembrane domain, releasing Aβ and the APP intracellular
domain (AICD) (De Strooper et al., 2012). The latter cleavage
has been enigmatic because the proteolysis occurs within the
membrane, that is, in the hydrophobic environment of the lipid
bilayer. γ-Secretase is a membrane-embedded atypical protease
comprised of four integral membrane proteins: presenilin (PS) 1
or PS2, nicastrin, Aph-1, and Pen-2 (De Strooper et al., 2012). PS
serves as the catalytic subunit (Wolfe et al., 1999). The three other
members play a role in the stabilization and maturation of the
complex. Nicastrin has also been implicated in the substrate bind-
ing (Shah et al., 2005). Besides the βCTF, γ-secretase cleaves many
type I membrane proteins including the Notch receptor, which
is responsible for cellular signaling during development and in
adults (De Strooper and Annaert, 2010). Recent structural stud-
ies for γ-secretase revealed that two catalytic Asp residues on the
transmembrane domains 6 and 7 of PS face the water-accessible
hydrophilic environment and act to catalyze the substrate prote-
olysis (Sato et al., 2006; Tolia et al., 2006; Li et al., 2013). Water
can gain access through the cavity surrounded by multiple trans-
membrane domains, as shown in other PS family proteases (Hu
et al., 2011; Li et al., 2013) and also in γ-secretase (Lu et al., 2014)
very recently. In contrast, the molecular mechanism underlying
the intramembrane cleavage of a substrate by γ-secretase is less
clear. A better understanding of how the βCTF is processed to
Aβ through intramembrane proteolysis by γ-secretase may help
establish an efficient disease modifying drug that specifically reg-
ulates Aβ42 production and/or does not have the adverse side
effects derived from the suppression of other substrate cleavages
(such as the Notch receptor) (Extance, 2010). The present review
covers the recent progress in the understanding of the molecu-
lar mechanism of the intramembrane proteolysis of the βCTF by
γ-secretase.
γ-CLEAVAGE AND ε-CLEAVAGE
ε-CLEAVAGE, A NOVEL FORM OF CLEAVAGE
Intramembrane cleavage of the βCTF by γ-secretase generates
an Aβ of ∼4 kDa and an AICD of ∼6 kDa (Figure 1A). The
AICD, a counterpart of the Aβ, is unstable in cells and has
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FIGURE 1 | γ-Cleavage and ε-cleavage by γ-secretase. (A) Schematic
illustration of γ- and ε-cleavages of the βCTF by γ-secretase.
γ-Cleavage generates Aβ40 and Aβ42; while, ε-cleavage generates
AICD50-99 and AICD49-99. There is a link between Aβ40 and
AICD50-99 and between Aβ42 and AICD49-99. (B) Comparison of
the γ-secretase-dependent intramembrane cleavage sites of various
γ-secretase substrates. γ-Cleavages (site 4 cleavages) and ε-cleavages
(site 3 cleavages) are shown by red and green arrowheads,
respectively. The shaded area represents the predicted
transmembrane domain. Either the human or rodent sequence is
shown based on the identification studies. The three residue-spaced
cleavages apply to the major γ- and ε-cleavage sites of APP, APLP1,
Notch1, and CD44. In alcadeinα, γ- and ε-cleavages occur at three
residue intervals, respectively.
been postulated to start at either Ile41 or Thr43 (Aβ num-
bering). However, protein sequencing and mass spectrometric
analysis of the AICD generated in vitro by cell-free or recon-
stituted Aβ generation systems revealed that the AICD starts at
Val50 or Leu49 (Aβ numbering) (Gu et al., 2001; Sastre et al.,
2001) and production of these AICDs was γ-secretase depen-
dent. The novel cleavage to generate the AICD (referred to as
ε-cleavage) (Weidemann et al., 2002) was located ∼10 amino
acids downstream of the Aβ generation sites (γ-cleavages), a
few residues inside the membrane-cytoplasmic boundary, and
is very similar to the site 3 cleavage of the Notch receptor
(Schroeter et al., 1998). In the Notch signaling, γ-secretase-
dependent Notch site 3 cleavage generates Notch intracellular
domain (NICD) that mediates the signaling cascade in a vari-
ety of cell biological processes (De Strooper and Annaert, 2010),
indicating the functional significance of this cleavage. Thus, γ-
secretase cleaves the transmembrane domain of the βCTF in at
least two sites: γ-cleavage generates Aβ while ε-cleavage gen-
erates the AICD. These dual cleavages are not inherent to the
βCTF of the APP, but also occur in other γ-secretase sub-
strates, such as APLP1/2 (Gu et al., 2001; Yanagida et al.,
2009), Notch (Schroeter et al., 1998; Okochi et al., 2002; Tagami
et al., 2008), CD44 (Okamoto et al., 2001; Lammich et al.,
2002), and alcadeins α/β/γ (Hata et al., 2009; Piao et al., 2013)
(Figure 1B).
A POTENTIAL LINK BETWEEN γ- AND ε-CLEAVAGES
The ε-cleavage is heterogeneous, similar to the γ-cleavage and the
two molecular species of the Aβ and AICD that are generated
appear to be linked (Figure 1A). In cells expressing wild-type
APP and/or wild-type PS1/2, Aβ40 and AICD50-99 were pre-
dominant, and Aβ42 and AIDC49-99 were minor species. When
various forms of FAD-mutant APP or FAD-mutant PS1/2 were
expressed in cells, the proportion of Aβ42 vs. Aβ40 increased with
a concomitant increase in the proportion of AICD49-99, although
the relationship was not the same (Sato et al., 2003). A low
concentration of the difluoro ketone peptidomimetic γ-secretase
inhibitor DFK-167, (N-[(S)-2,2-difluoro-3-oxo-4-[(Boc-L-Val-
L-Ile-)amino]pentanoyl]-L-Val-L-Ile-OMe), induced an increase
in Aβ42, which also caused an increase in AICD49-99 (Sato et al.,
2003). Thus, there is a link between Aβ40 and AICD50-99 and
between Aβ42 and AICD49-99. A close relation between γ- and
ε-cleavages was also suggested by the observation that APP FAD-
mutations close to the ε-cleavage site (V717F, L723P) and the
γ-cleavage site (T714I, V715A) influenced ε-cleavage as well as
γ-cleavage, with remarkable increases in Aβ42 and AICD49-99
(Kakuda et al., 2006; Dimitrov et al., 2013).
ε-CLEAVAGE PRECEDES γ-CLEAVAGE
The potential link between Aβ42 and AICD49-99 raises a ques-
tion: which cleavage, γ- or ε-, occurs first? It is likely that the
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ε-cleavage occurs first for the following reasons. First, the ε-
cleavage site is located in close proximity to the cytoplasm,
where water is available. In addition, the longest AICD detected
so far in studies was AICD49-99. Thus, the ε-cleaved βCTFs
of longer Aβs (Aβ49 and Aβ48) must then undergo γ-cleavage
for Aβ generation. To test this proposal, Aβ49 and Aβ48 were
overexpressed in cells and the molecular species of Aβ gener-
ated were investigated (Funamoto et al., 2004). The expression
of Aβ49, a counterpart of AICD50-99, generated predominantly
Aβ40; while, the expression of Aβ48, a counterpart of AICD49-
99, preferentially produced Aβ42. These findings support the idea
that ε-cleavage occurs first. Note that the expression of Aβ51,
which is three residues longer than Aβ48, also produced predom-
inantly Aβ42 (Funamoto et al., 2004). Thus, longer Aβs generated
through ε-cleavage are processed to Aβ40/Aβ42 by γ-secretase.
Moreover, the initial ε-cleavage sites determine the subsequent
γ-cleavage sites and the type of Aβ species produced.
STEPWISE SUCCESSIVE PROCESSING OF LONGER Aβs BY
γ-SECRETASE GENERATES Aβ40 AND Aβ42
LONGER Aβs ARE INTERMEDIATE PRODUCTS PRESENT IN CELLS
When ε-cleavage precedes γ-cleavage, longer Aβs should be
produced. Thus, it is important to identify these intermedi-
ate molecules. The corresponding intermediates, which are Aβ
species longer than Aβ1-42, are retained in themembrane inmin-
imal amounts, if any. These Aβ species were immunoprecipitated
with the Aβ N-terminus specific antibody from the membrane
fraction and analyzed by Western blotting using a modified
SDS/urea gel system that could distinguish Aβ37 through Aβ49,
even when the Aβ species varied by only one residue (Qi-Takahara
et al., 2005). Longer Aβs, including Aβ43, Aβ45, Aβ46, and Aβ48,
were identified in the cells and in mouse brains. Their produc-
tion was γ-secretase dependent. In our hands, Aβ49 was hardly
detectable. In cells expressing wild-type APP and/or wild-type PS,
the major intracellular Aβ species were Aβ40, Aβ43, and Aβ46,
and the minor ones were Aβ42, Aβ45, and Aβ48. In cells express-
ing mutant APP or mutant PS, decreases in Aβ40 and increases in
Aβ42 sometimes accompanied decreased levels of Aβ43 and Aβ46
and increased levels of Aβ45 and Aβ48; however, the coordination
was not always obvious (Qi-Takahara et al., 2005).
Thus, γ-secretase cleaves the transmembrane domain of the
βCTF at multiple sites (Figure 2A). The cleavage site between the
γ- and ε-cleavage sites is called the ζ-site (Zhao et al., 2004). These
cleavage sites appear to be divided into two groups, the sites rele-
vant to Aβ40 production (Aβ43, Aβ46, Aβ49) and those relevant
to Aβ42 production (Aβ45, Aβ48). The cleavage at three residue
intervals is a prominent property in each group. This notion is
supported also by the observation that the V721K APP muta-
tion led to increased AICD47-99 (a counterpart of Aβ46) and a
concomitant increase in Aβ40.
STEPWISE SUCCESSIVE PROCESSING BY γ-SECRETASE GENERATES
Aβ
Interestingly, dose-dependent treatment with DAPT (N-[N-(3,5-
difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester), a
potent dipeptide γ-secretase inhibitor, caused differential accu-
mulations of longer Aβs in the cells that inducibly expressed the
FIGURE 2 | Stepwise successive processing of the βCTF by γ-secretase
generates Aβ. (A) There are two major product lines generating Aβ40 and
Aβ42, respectively. Aβ49, a major ε-cleaved product, is converted to Aβ40
through Aβ46 and Aβ43, which accompanies the release of the tripeptides
ITL, VIV, and IAT. Aβ48, a minor ε-cleaved product, is converted to Aβ42
through Aβ45, releasing the tripeptides VIT and TVI. These pathways are
estimated to represent ∼75% of total Aβ production. Part of Aβ42 is further
converted to Aβ38, releasing a tetrapeptide VVIA. Red and green
arrowheads represent γ- and ε-cleavages, respectively. (B) Schematic
illustration of the multiple interactive pathways for stepwise successive
cleavages of the βCTF by membrane-integrated γ-secretase. The data on
the peptides released by raft-associated γ-secretase (Matsumura et al.,
2014) are summarized. Besides two major Aβ product lines shown in (A),
many alternative cleavages occur, releasing peptides with three to six
residues. These minor routes link the two major pathways in an interactive
manner and modulate Aβ production. It is likely that ε–cleavage generates
trace amounts of Aβ51 and Aβ50 in addition to Aβ49 and Aβ48 (blue letters)
(see Sato et al., 2003; Olsson et al., 2014). Black, gray, and white arrows
represent the release of tri-, tetra-, and penta-peptides, respectively. A
dotted arrow represents the release of a hexapeptide. The relative
thicknesses of the arrow represent the amount of the released peptides.
Note that most Aβ38 is generated either from Aβ42 or Aβ43 by the release
of a tetrapeptide or pentapeptide.
βCTF (Qi-Takahara et al., 2005). A decrease in Aβ40 levels accom-
panied a transient increase in Aβ43, which, in turn, brought
about a transient increase in Aβ46. One plausible explanation
for this observation would be the precursor-product relation-
ship. Suppression of Aβ40 results in accumulation of its pre-
cursor molecule, Aβ43, and subsequently, suppression of Aβ43
induces accumulation of its precursor Aβ46. Thus, it is reason-
able to speculate that Aβ40 is produced successively from Aβ46
through Aβ43. In contrast to the wild-type cells, dose-dependent
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treatment with DAPT did not induce dramatically different intra-
cellular accumulations of Aβ in a consistent manner in mutant
PS cells (Yagishita et al., 2006). PS2 cells with the N141I muta-
tion exhibited a remarkable decrease in Aβ42 and a concomi-
tant increase in Aβ45, while M233T mutant PS1 cells showed a
decrease in Aβ42, which accompanied a slight transient increase
in Aβ48.
These results led us to propose the stepwise successive pro-
cessing model by γ-secretase for Aβ generation (Qi-Takahara
et al., 2005) (Figure 2A). In this model, γ-secretase cleaves the
βCTF first at the ε-cleavage site close to the membrane-cytoplasm
boundary and the truncated βCTF (longer Aβs) generated is pro-
cessed from the C-terminus at every third residue. According
to the model, Aβ49, a major ε-cleaved product, is converted to
Aβ40 through Aβ46 and Aβ43, releasing the tripeptides ITL, VIV,
and IAT. The other minor ε-cleaved product, Aβ48, is converted
to Aβ42 through Aβ45, releasing the tripeptides VIT and TVI.
Consistent with this model, treatment of cells with DAPT caused
accumulation of Aβ46 in lipid rafts, which was processed to Aβ40
and Aβ43, but not Aβ42, in a γ-secretase-dependent manner
through in vitro incubation of the isolated rafts (Yagishita et al.,
2008).
TRIPEPTIDES ARE RELEASED CONCOMITANTLY WITH Aβ GENERATION
The identification of the tripeptides released by γ-secretase dur-
ing Aβ generation provides convincing evidence for this cleavage
model. These tripeptides were directly identified and quanti-
fied in the reaction mixture of a CHAPSO-solubilized recon-
stituted γ-secretase system using liquid chromatography with
tandem mass spectrometry (LC-MS/MS) (Takami et al., 2009);
in this system, the βCTF purified from Sf9 cells was used as a
substrate. The predicted five tripeptides were all identified by
LC-MS/MS. Three tripeptides in the putative Aβ40-product line
(IAT, VIV, and ITL) and two tripeptides in the putative Aβ42-
product line (TVI and VIT) were released concomitantly with
Aβ generation. Additionally, a released tetrapeptide, VVIA, was
identified, although in relatively low amounts (Figure 2A). This
finding indicated that a part of Aβ42 is converted to Aβ38 by
releasing VVIA. The release of those peptides was suppressed
by γ-secretase inhibitors, indicating that their generation was γ-
secretase-dependent. Similar tri- and tetrapeptides were released
using synthetic Aβ peptides as substrates (Okochi et al., 2013).
The quantification of the released peptides further validated the
accuracy of the model (Takami et al., 2009). The relative relation-
ships of the peptides were: ITL > VIV > IAT and VIT > TVI
>> VVIA, which fitted the model. The Aβ levels estimated by the
tripeptide amounts, according to the model, corresponded well
with the levels determined by Western blotting. Thus, the pro-
posed stepwise processing model is reasonable and there are two
product lines: Aβ49 -> Aβ46 -> Aβ43 -> Aβ40 and Aβ48 ->
Aβ45 -> Aβ42 (-> Aβ38) (Figure 2A).
MULTIPLE INTERACTIVE PATHWAYS FOR STEPWISE SUCCESSIVE
PROCESSING GENERATE Aβ
Lipid rafts are detergent-resistant membrane microdomains
enriched in cholesterol and sphingolipids and play a significant
role in Aβ generation in cells (Vetrivel and Thinakaran, 2010).
These rafts exclusively contain all four components required for
the active γ-secretase complex: the PS N-terminal fragment/C-
terminal fragment, mature nicastrin, Aph-1, and Pen-2 (Wada
et al., 2003; Vetrivel et al., 2004), indicating that active γ-secretase
is present in lipid rafts (Hur et al., 2008). In addition, the lipid
composition in the membrane of the rafts is favorable for γ-
secretase activities: both cholesterol and sphingolipids have been
shown to enhance its activities (Osenkowski et al., 2008). Thus,
these lipid rafts can provide the proper lipid environment for Aβ
generation, as seen in the in vitro Aβ generation systems, which
exhibited higher γ-secretase activity in lipid rafts (Wada et al.,
2003; Hur et al., 2008).
The membrane integrity of γ-secretase was not considered
in the studies discussed above. Therefore, we assessed whether
membrane-integrated γ-secretase followed the cleavage model
using γ-secretase associated with lipid rafts. The reaction mix-
ture of the in vitro reconstituted γ-secretase system with lipid
raft-associated γ-secretase was subjected to LC-MS/MS analyses
to identify the small peptides released from the transmembrane
domain of the βCTF during Aβ generation (Matsumura et al.,
2014). Similar to the CHAPSO-solubilized system, the predicted
5 tripeptides, IAT, VIV, ITL, TVI, and VIT, and the tetrapeptide,
VVIA, were released in a γ-secretase-dependent manner with Aβ
generation. The same quantitative relationships, ITL>VIV>IAT
and VIT>TVI>>VVIA, were also present. Thus, raft-associated
γ-secretase cleaves the transmembrane domain of the βCTF in
a stepwise successive manner at every third or fourth residue to
generate Aβ40 and Aβ42 (Aβ38). However, Aβ generation by raft-
associated γ-secretase accompanied the release of novel penta-
and hexapeptides, as well as tri- and tetrapeptides. Although
they were in low amounts and the original two pathways that
generated Aβ40 and Aβ42 amounted to ∼75% of total Aβ
production (Matsumura et al., 2014), the clipping of the novel
peptides, in particular pentapeptides, links the above two major
pathways at several points and allows for an alternative route
for successive cleavages (Figure 2B). The presence of multiple
interactive pathways for the stepwise cleavages of the βCTF
could modulate the nature of the species and the quantity of Aβ
generated. In fact, these interactive pathways could provide a
better explanation for several previous studies apparently incon-
sistent with the model that affords two Aβ product lines (see
Matsumura et al., 2014). Similar three- to six-residue peptides
were also released and identified in the cell-free Aβ generation
system with an endogenous substrate, where no detergent was
used (Olsson et al., 2014). In this study, small amounts of Aβ40
and Aβ42 continued to be processed in a stepwise manner, being
further converted into smaller Aβs such as Aβ37, Aβ36, and Aβ34
(Olsson et al., 2014). It is worth noting that Aβ38 and Aβ43
may be generated via three routes, releasing a tri-, tetra-, and
penta-peptide, respectively, (Figure 2B). γ-Secretase modulators
(GSMs), such as GSM-1 ((2S,4R)-1-[(R)-1-(4-chlorophenyl-4-
methylpentyl)-2-(4-trifluoromethylphenyl)piperidin-4-yl]acetic
acid), can selectively lower Aβ42 levels and are a prospective
therapeutic tool for AD. These modulating compounds enhanced
all three routes that generate Aβ38 and the conversion of Aβ40
to Aβ37. Significant decreases in conventional Aβs (Aβ42, Aβ43,
and Aβ40) occurred as well as increases in the levels of shorter
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Aβs (Aβ38 and Aβ37) (Takami et al., 2009; Okochi et al., 2013;
Matsumura et al., 2014; Olsson et al., 2014). Thus, the influence
of GSMs is not limited to a single pathway (the conversion of
Aβ42 to Aβ38), but advances the stepwise cleavage by γ-secretase
one step further, generating shorter Aβ species.
It is possible that in the proper lipid environment, γ-secretase
favors certain cleavage sites over others, resulting in differences
in cleavage products when the protease is CHAPSO-solubilized
vs. membrane-integrated. Cholesterol may modulate the cleav-
age specificity of γ-secretase (Osenkowski et al., 2008). However,
a pentapeptide VVIAT was released by CHAPSO-solubilized γ-
secretase with large amounts of synthetic Aβ43 as a substrate
(Okochi et al., 2013). Thus, it is more likely that the variable
cleavages that occur as a consequence of the surrounding con-
ditions are an inherent property of γ-secretase. When γ-secretase
had higher activity in the membrane environment, a number of
co-released minor peptides would be easily identified.
Most FAD mutations on PS impair the γ-secretase activi-
ties. Some mutations on PS1 reduced the cropping activity of
γ-secretase (Okochi et al., 2013; Fernandez et al., 2014) and led
to accumulation of longer Aβs such as Aβ43, Aβ45, and Aβ46
(Shimojo et al., 2008; Quintero-Monzon et al., 2011). While Aβ43
is another neurotoxic Aβ species (Saito et al., 2011), the toxicity
and aggregation properties of Aβ45 and Aβ46 are not yet under-
stood. However, it is possible that the accumulation of longer
Aβ induces further impairment of the γ-secretase function and
accelerates the disease progression. The observation by Yagishita
et al. (2008) that Aβ46 accumulated in the presence of DAPT was
converted to Aβ40 and Aβ43 even in the presence of L-685,458
([1S-benzyl-4R-(1S-carbamoyl-2-phenylethylcarbamoyl-1S-3-
methylbutylcarbamoyl)-2R-hydroxy-5-phenylpentyl] carbamic
acid tert-butyl ester), a transition state analog γ-secretase
inhibitor, indicated that Aβ46 generated as an intermediate
remains bound to the catalytic site of γ-secretase. The altered
binding kinetics of Aβ46 may result in disturbed turnover of
γ-secretase.
Proteolytic cleavage of the α-helix generally requires local
unwinding to expose a scissile peptide bond to the catalytic site of
the protease. The initial endopeptidase-like cleavage of the βCTF
by γ-secretase may be facilitated by the flexible loose structure
around the ε-cleavage site, which has been revealed by NMR (Sato
et al., 2009; Lu and Tycko, 2011). Since ε-cleaved long Aβ (Aβ49 or
Aβ48) is hardly detectable in any system (Qi-Takahara et al., 2005;
Kakuda et al., 2006), it is likely that cropping proceeds swiftly in
the same cellular compartment (Qi-Takahara et al., 2005), once
ε-cleavage is initiated. The cleavage sites aligned on the surface of
the α-helix of the βCTF transmembrane domain (∼3.6 residues
for one turn of α -helix) may encourage the recognition and/or
proteolysis by γ-secretase (Qi-Takahara et al., 2005). The obser-
vations of the major three-residue spaced stepwise processing
and the differential sensitivity to DAPT observed among cleav-
age sites are consistent with this assumption (Qi-Takahara et al.,
2005). On the other hand, the release of tetra- and pentapep-
tides, in addition to tripeptides, may also support the theory that
the fraying helix terminus generated by the cleavage promotes
the next cleavage (Sato et al., 2009; Pester et al., 2013). Future
structural studies may uncover hidden enzymatic properties of
γ-secretase, as the recent identification of a structure homolo-
gous to carboxypeptidase within the structure of nicastrin (Lu
et al., 2014). The termination of the stepwise processing should
release Aβ. Glycine residues in the transmembrane domain may
determine the termination point (Munter et al., 2007; Pester et al.,
2013; Lemmin et al., 2014). Alternatively, Aβ may be released
due to decreased hydrophobicity of the shortened Aβ stub. The
absence of glycine residues in the Notch and CD44 transmem-
brane domain (Figure 1B) supports the latter possibility. Either
way, the primary cleavage site (γ-, ε-, or ζ-) appears to be criti-
cal in determining the final Aβ species produced. The properties
of amino acids lining the cleavage sites are also important in
determining the cleaved residues, because substitutions of those
amino acids generated alternative cleavage sites (Lichtenthaler
et al., 1999; Sato et al., 2005).
CONCLUDING REMARKS
The successive tripeptide-cropping pathway is the basal
framework for the βCTF cleavage by the membrane-integrated
γ-secretase, but many alternative cleavages occur to release three-
to six-residue peptides. There is crosstalk between the pathways
involved in stepwise successive processing for Aβ generation
by γ-secretase. The stepwise sequential processing mechanism
may be a general property of intramembrane proteolysis by the
γ-secretase family of proteases (see Figure 1B). Several residue-
spaced cleavages have also been identified in PS (Fukumori
et al., 2010) and in tumor necrosis factor-α (a substrate of
signal peptide peptidase-like protein) (Fluhrer et al., 2006).
Cleavage at three residue intervals appears to be favorable at least
for γ-secretase, but it is not required. The stepwise successive
processing by γ-secretase may be at work to metabolize various
membrane-spanning proteins in the membrane as with the
proteasome in the cytoplasm (Kopan and Ilagan, 2004), since
small peptides are promptly released from the membrane. On
the other hand, γ-secretase-mediated endoproteolysis plays a
critical role in cellular signaling: shedding-primed ε-like cleavage
modulates cellular signaling pathways through the released
C-terminal intracellular domain (ICD), as typically observed
in the Notch receptor (De Strooper and Annaert, 2010). Thus,
γ-secretase may have two distinct physiological functions cou-
pled with the proteolysis. In addition, both functions may be
coordinated.
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